All analyses
AI analysis

Hemas Holdings Ltd.: research report

Moderately undervaluedbullishNov 11, 2026

Evidence points bullish because September revenue rose 17.1% and the shares trade below sector earnings multiples. The catch is that net profit slipped as finance costs climbed sharply.

Today's public report is ready. The next one can be generated tomorrow. Add a focus below for your own private research.

Reports without a focus are public, one per stock per day. Generation usually takes about 15 minutes, and we'll notify you when it's ready.

Why bullish

  • September-quarter revenue grew 17.1% and operating profit grew 8.1%, showing that the core businesses expanded despite cost pressure.
  • At 11.1 times earnings, the shares cost about LKR 11 for each LKR 1 of trailing profit, below the diversified-holdings median of 14.83 times.
  • The latest audited year delivered 15.7% return on equity, supporting a P/B above the sector median.

Against this. September-quarter net profit fell 1.7% as finance costs rose 149.4%, showing that stronger sales are not yet fully reaching shareholders.

Operating margin
10.0%sector 9.7%
from 10.8% a year earlier
Net margin
5.6%sector 3.0%
from 6.7% a year earlier, revenue +17.1%
Return on equity
15.0%
twelve months to Sep 30, 2026, unaudited
P/E
11.4sector 14.2
earnings Rs 2.87 per share, year to Sep 2026
P/B
1.71sector 1.20
book Rs 19.22 per share
Dividend yield
3.05%sector 2.08%
34.8% of earnings paid out

Current figures, updated daily from filings to Sep 30, 2026. The report below was written on Nov 11, 2026. Sector figures are the median of 22 listed companies in the same sector.

Overview

Hemas is a diversified Sri Lankan group spanning healthcare, consumer brands, mobility, leisure, travel, aviation, logistics and maritime services. The latest quarter showed a clear split: sales and operating profit grew, but higher finance costs left net profit slightly lower. Healthcare is the largest reported segment exposure, while the consumer business and the newly acquired Kenyan stationery platform add both growth avenues and execution demands.

Price performance

The share gained 6.7% over three months, ahead of the ASPI's 2.9%, but was down 4.3% over one year against a 3.9% fall in the index. The valuation measures in this analysis use the LKR 33.00 close on 11 November 2026.

At 62.4% of its 52-week range, the price sat above the midpoint between its LKR 28.00 low and LKR 36.50 high. Sixty-day volatility was 34.0% below its own one-year norm, while trading volume was 21.6% above the recent 60-day norm, indicating quieter price movement alongside firmer activity.

The three-year record is two falls of 15% or more, the deepest 24%, which took seven months to recover. Median daily turnover was LKR 5.0 million; a LKR 1 million order is about 20% of what trades on a typical day, a noticeable part of a day's trading.

Valuation

At 11.1 times trailing earnings, a buyer pays about LKR 11 for each LKR 1 of the last twelve months' profit, below the sector median of 14.83 times. The P/E sits at the 38th percentile among the 17 sector peers with reported earnings multiples, so it is cheaper than much of the peer set rather than an extreme outlier.

The 1.72 times P/B means paying LKR 1.72 for each LKR 1 of net assets, above the sector median of 1.20 times. That premium is partly reconciled by the latest audited 15.7% return on equity. However, the shares are more expensive than 77% of days since January 2019 on P/B, while they are cheaper than 62% of days on P/E. The valuation therefore relies more on current earnings than on a cheap entry against book value.

The 3.0% dividend yield exceeds the 2.5% sector median. Dividends rose from LKR 0.68 in FY2024 to LKR 0.90 in FY2025 and LKR 1.00 in FY2026, while the LKR 1.00 trailing payout is covered 2.98 times by earnings. The latest quarter supplied 23.4% of trailing EPS; its 5.6% net margin was below the year-ago 6.7%, and matching that earlier margin would put the P/E at 10.6 times rather than 11.1 times.

News and sentiment

Company coverage was about normal, with five articles in the last 30 days against a monthly baseline of 3.2. Over 90 days, material coverage was closely split between 12 positive and 10 negative articles, with three neutral.

Results reported on 6 November confirmed first-half revenue growth of 9.5% and identified finance costs from working-capital borrowings and the Twiga acquisition as the reason earnings fell. Hemas acquired 75% of Kenya's Twiga Stationers and Printers for US$16.2 million, its first overseas acquisition; the disclosed material does not quantify Twiga's revenue or profit contribution. A first interim dividend of LKR 0.25 has a confirmed ex-date of 16 November 2026 and payment date of 4 December 2026.

Financials

September-quarter revenue rose 17.1% to LKR 37.8 billion and operating profit rose 8.1% to LKR 3.8 billion, but net profit fell 1.7% to LKR 2.1 billion. The difference was below operations: LKR 1.7 billion was absorbed by finance costs, tax, associates and other below-line items, against LKR 1.3 billion a year earlier. The group basis is consistent with the year-ago quarter, making the comparison like-for-like.

Gross margin was 29.7% versus 32.8% a year earlier, operating margin was 10.0% versus 10.8%, and net margin was 5.6% versus 6.7%. The September gross margin ranked a middling fifth of eight comparable September quarters, operating margin fourth of eight, and net margin third of eight. This was not an unusually weak September by the company's own record, but a lower share of each sales rupee reached profit.

Total equity rose to LKR 59.6 billion from LKR 51.7 billion a year earlier. The September filing used 3.0 billion shares, versus 3.0 billion a year earlier; the 1:5 subdivision took effect in May 2025, before both September comparison periods, so the latest year-on-year profit comparison is not mechanically distorted by that action.

Risks

The leading risk is a heavier financing burden. September total debt was LKR 18.4 billion against cash of LKR 13.3 billion, while finance costs were markedly higher year-on-year. This leaves earnings more exposed to borrowing costs and to the working-capital needs of a larger group, including Twiga.

The latest audited balance sheet, for March 2026, was nevertheless conservatively funded: gearing, meaning debt against owners' equity, was 10.8%, and interest cover was 13.79 times, meaning operating profit covered the interest bill nearly fourteen times. The current ratio was 1.72 times, so short-term assets including inventory and receivables exceeded bills due within a year. Cash conversion was 0.83 times, meaning only 83 cents of each rupee of operating profit arrived as operating cash in that year, a useful caution on the quality of reported profit.

Consumer retail represents 38% of reported segment revenue and faces an environment of higher inflation, fuel costs and pressure on household purchasing power. Healthcare, at 62% of reported segment revenue, is the larger exposure; sector material was quiet and does not establish a company-specific benefit.

Outlook

As at 11 November 2026, the next material update is the December 2026 interim quarter, expected to be filed between 3 and 14 February 2027. It should show whether the strong September sales growth and the Twiga acquisition are contributing enough operating profit to offset the higher finance burden.

The confirmed LKR 0.25 interim dividend goes ex on 16 November 2026; only a buyer before that day receives it. The available data cannot yet separate Twiga's earnings contribution or determine whether the September financing pressure is temporary or persists.

About this report. Generated on Nov 11, 2026 from market data up to Nov 11, 2026, 25 material news articles over 90 days and financials to Sep 30, 2026, and scored 64 of 100 on value (moderately undervalued) when it was written. Every figure is drawn from EquityLK's own data on this company. AI research can contain errors, so treat it as a starting point, not investment advice.

Previous reports